$0.34
▼ $0.02 (-5.8%)
NXL
Nexalin Technology Inc. Common Stock
Health Care
Investor Score
41D
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
9
Technical
38
Fundamental
60
Growth
50
Fair Value
62
News
58
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.